celastrol has been researched along with transforming growth factor beta in 5 studies
| Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) | Studies (transforming growth factor beta) | Trials (transforming growth factor beta) | Recent Studies (post-2010) (transforming growth factor beta) |
|---|---|---|---|---|---|
| 885 | 1 | 741 | 49,119 | 560 | 17,610 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, Z; Xu, C | 1 |
| Chen, J; Chen, JX; Chen, XB; Chen, Y; Gu, YT; Shi, KS; Wang, XY; Wu, YS; Xie, JJ; Xuan, J; Zhang, XL; Zheng, ZM | 1 |
| Divya, T; Sudhandiran, G; Velavan, B | 1 |
| Kim, J; Lee, YJ; Shin, HW | 1 |
| Wu, M; Zhang, Y | 1 |
5 other study(ies) available for celastrol and transforming growth factor beta
| Article | Year |
|---|---|
[The effect of tripterine in prevention of glomerulosclerosis in lupus nephritis mice].
Topics: Animals; Antibodies, Antinuclear; Female; Glomerulosclerosis, Focal Segmental; Immunohistochemistry; Kidney; Lupus Nephritis; Mice; Pentacyclic Triterpenes; Proteinuria; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Triterpenes | 2002 |
Celastrol reduces IL-1β induced matrix catabolism, oxidative stress and inflammation in human nucleus pulposus cells and attenuates rat intervertebral disc degeneration in vivo.
Topics: ADAMTS5 Protein; Aggrecans; Animals; Cell Death; Cell Nucleus; Cell Survival; Collagen Type II; Cyclooxygenase 2; Cytoprotection; Extracellular Matrix; Gene Expression Regulation; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Intervertebral Disc Degeneration; Magnetic Resonance Imaging; Male; NF-kappa B; Nitric Oxide Synthase Type II; Nucleus Pulposus; Oxidative Stress; Pentacyclic Triterpenes; Protein Transport; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta; Triterpenes; Tumor Necrosis Factor-alpha | 2017 |
Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis.
Topics: A549 Cells; Animals; Bleomycin; Cadherins; Disease Models, Animal; Drugs, Chinese Herbal; Epithelial Cells; Epithelial-Mesenchymal Transition; Humans; Lung; Male; Pentacyclic Triterpenes; Pulmonary Fibrosis; Rats; Rats, Wistar; Signal Transduction; Smad Proteins; Transforming Growth Factor beta; Tripterygium; Triterpenes | 2018 |
Role of c-Myb in the regulation of natural killer cell activity.
Topics: Cell Line; Cell Proliferation; Cytotoxicity, Immunologic; Gene Expression Regulation; Granzymes; Humans; Immunologic Factors; Interferon-gamma; Interleukin-2; Intracellular Signaling Peptides and Proteins; Killer Cells, Natural; Lymphocyte Activation; NK Cell Lectin-Like Receptor Subfamily K; Pentacyclic Triterpenes; Primary Cell Culture; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-myb; Proto-Oncogene Proteins c-myc; RNA, Small Interfering; Signal Transduction; Transforming Growth Factor beta; Triterpenes | 2018 |
Combining bioinformatics, network pharmacology and artificial intelligence to predict the mechanism of celastrol in the treatment of type 2 diabetes.
Topics: ADAMTS Proteins; Artificial Intelligence; Computational Biology; Diabetes Mellitus, Type 2; Gene Expression Profiling; Humans; Molecular Docking Simulation; Network Pharmacology; Transforming Growth Factor beta | 2022 |